AI Science Tracker
EN

State Key Laboratory of Respiratory Health and Multimorbidity

1 discovery from 2025

Discoveries

Multi-omics characterization of early chronic obstructive pulmonary disease

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Integrated multi-omics analysis in clinically confirmed early COPD cases and controls identifies molecular differences and candidate pathways associated with early disease. The study combines clinical CPHS cohort data with models; supports disease-specific multi-omics characterization, limited to the discovery cohort and exploratory interpretation.

Technology: Original Methods text examined; the learned-model operation is identified and linked to the summarized result.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Original Methods text examined; the learned-model operation is identified and linked to the summarized result.
Limitation / still unknown
The result is limited to the reported dataset, experimental setting and validation in this study; broader generalization and real-world benefit are not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://link.springer.com/article/10.1186/s12931-025-03250-5 · https://pubmed.ncbi.nlm.nih.gov/40296012/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.